Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar Survivn2 (68.50) Submitted: 8/12/2009 3:49:57 AM : Outperform Start Price: $8.64 OMPI Score: +13.79

going with motley fool 5star on this one...schwab rates "c"

Featured Broker Partners


Advertisement